Stefanie Julia Willmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Stefanie Julia Willmann has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Aurelia Raducanu
Institute of Diabetes and Regeneration Research, Institute of Stem Cell Research, Helmholtz Zentrum München, Business Campus Garching, Parkring 11, 85748 Garching, Germany
1 shared publication- Christian Johannes Gloeckner
German Center for Neurodegenerative Diseases (DZNE)
1 shared publication Christian Klein
Max‐Planck‐Institute for Biochemistry, Department of Membrane Biochemistry, Martinsried, Germany
1 shared publication- Fabian Joachim Theis
Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK
1 shared publication - Hans Zischka
Institute of Toxicology and Environmental Hygiene, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany
1 shared publication - Heiko Lickert
Institute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany
1 shared publication
Latest Publications
- Open Access
- 10 June 2021
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 43 (2) , 847
Correction to: Cutting the edge between cancerogenesis and organogenesis of the pancreatic endocrine lineage allocation—comprehensive review of the genes Synaptotagmin 13 and 533041C22 Rik in epithelial-to-mesenchymal transition
A Correction to this paper has been published: https://doi.org/10.1007/s10555-021-09978-y
- 10 June 2021
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 43 (2) , 847
Open AccessCorrection to: Cutting the edge between cancerogenesis and organogenesis of the pancreatic endocrine lineage allocation—comprehensive review of the genes Synaptotagmin 13 and 533041C22 Rik in epithelial-to-mesenchymal transition
A Correction to this paper has been published: https://doi.org/10.1007/s10555-021-09978-y
- Open Access
- 24 May 2020
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 39 (3) , 953-958
Cutting the edge between cancerogenesis and organogenesis of the pancreatic endocrine lineage allocation—comprehensive review of the genes Synaptotagmin 13 and 533041C22 Rik in epithelial-to-mesenchymal transition
In the past years, a multitude of studies has been published in the field of pancreatic organogenesis to interrogate the critical regulators of endocrine lineage segregation. Preliminary, transcription factors are guiding the transcriptional hierarchy of the endocrine specified cells, underpinning the importance of open chromatin formation. Signaling pathways either inhibit or accelerate the transcriptional landscape of pancreatic organogenesis. Thus, the fine-tuned process in the former pancreatic multipotent progenitors in the mechanism of lineage segregation needs to be elucidated more precisely for unraveling the temporal-spatial lineage-determining factors.Previously, Willmann et al. described candidate gene regulators of lineage segregation during the secondary transition of pancreatic organogenesis. At embryonic stage (E) 12.5, the former multipotent pancreatic progenitor compartmentalizes into the acinar, ductal, and endocrine lineage. In the adult pancreatic gland, acinar cells secrete enzymes that are transported by the duct to the duodenum. In contrast, the endocrine cells are clustered within the acinar tissue in the Islets of Langerhans. These Islets of Langerhans consist of a subset of α, δ, ε, and PP cells and β cells, and the function of the α and β cells is predominantly described by regulating glucose homeostasis, contrary, the function of the additional subtypes in the Islets of Langerhans remains still unclear and is rather pointing to a supportive role for the α and β cells.The essential wave of endocrine precursor cells emerges at E 14.5 out of the ductal cord-like structure in a process called epithelial-to-mesenchymal transition (EMT). This EMT is a reversible and incomplete process that includes significant intermedia states. As EMT is in focus in the field of cancer research, missense in endocrine lineage segregation is linking to a progression of pancreatic cancer, to be more precise in adenocarcinoma, e.g., meaning pancreatic ductal adenocarcinoma.Thus, the previous review will further accelerate the understanding of EMT about endocrine lineage segregation, respective pancreatic ductal adenocarcinoma, and introduces factors previously only known for either lineage segregation or related in cancer disease into a complete picture.
- 24 May 2020
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 39 (3) , 953-958
Open AccessCutting the edge between cancerogenesis and organogenesis of the pancreatic endocrine lineage allocation—comprehensive review of the genes Synaptotagmin 13 and 533041C22 Rik in epithelial-to-mesenchymal transition
In the past years, a multitude of studies has been published in the field of pancreatic organogenesis to interrogate the critical regulators of endocrine lineage segregation. Preliminary, transcription factors are guiding the transcriptional hierarchy of the endocrine specified cells, underpinning the importance of open chromatin formation. Signaling pathways either inhibit or accelerate the transcriptional landscape of pancreatic organogenesis. Thus, the fine-tuned process in the former pancreatic multipotent progenitors in the mechanism of lineage segregation needs to be elucidated more precisely for unraveling the temporal-spatial lineage-determining factors.Previously, Willmann et al. described candidate gene regulators of lineage segregation during the secondary transition of pancreatic organogenesis. At embryonic stage (E) 12.5, the former multipotent pancreatic progenitor compartmentalizes into the acinar, ductal, and endocrine lineage. In the adult pancreatic gland, acinar cells secrete enzymes that are transported by the duct to the duodenum. In contrast, the endocrine cells are clustered within the acinar tissue in the Islets of Langerhans. These Islets of Langerhans consist of a subset of α, δ, ε, and PP cells and β cells, and the function of the α and β cells is predominantly described by regulating glucose homeostasis, contrary, the function of the additional subtypes in the Islets of Langerhans remains still unclear and is rather pointing to a supportive role for the α and β cells.The essential wave of endocrine precursor cells emerges at E 14.5 out of the ductal cord-like structure in a process called epithelial-to-mesenchymal transition (EMT). This EMT is a reversible and incomplete process that includes significant intermedia states. As EMT is in focus in the field of cancer research, missense in endocrine lineage segregation is linking to a progression of pancreatic cancer, to be more precise in adenocarcinoma, e.g., meaning pancreatic ductal adenocarcinoma.Thus, the previous review will further accelerate the understanding of EMT about endocrine lineage segregation, respective pancreatic ductal adenocarcinoma, and introduces factors previously only known for either lineage segregation or related in cancer disease into a complete picture.
- 1 February 2016
- Published by Elsevier in Mechanisms of Development
- Vol. 139, 51-64
The global gene expression profile of the secondary transition during pancreatic development
- 1 February 2016
- Published by Elsevier in Mechanisms of Development
- Vol. 139, 51-64
The global gene expression profile of the secondary transition during pancreatic development
- 2 December 2004
- Published by Wiley in Proteomics
- Vol. 4 (12) , 3776-3782
Improved mass spectrometric identification of gel‐separated hydrophobic membrane proteins after sodium dodecyl sulfate removal by ion‐pair extraction
Separation and identification of hydrophobic membrane proteins is a major challenge in proteomics. Identification of such sodium dodecyl sulfate‐polyacrylamide gel electrophoresis (SDS‐PAGE)‐separated proteins by peptide mass fingerprinting (PMF) via matrix‐assisted laser desorption/ionization‐time of flight (MALDI‐TOF) is frequently hampered by the insufficient amount of peptides being generated and their low signal intensity. Using the seven helical transmembrane‐spanning proton pump bacteriorhodopsin as model protein, we demonstrate here that SDS removal from hydrophobic proteins by ion‐pair extraction prior to in‐gel tryptic proteolysis leads to a tenfold higher sensitivity in mass spectrometric identification via PMF, with respect to initial protein load on SDS‐PAGE. Furthermore, parallel sequencing of the generated peptides by electrospray ionization‐mass spectrometry (ESI‐MS) and tandem mass spectrometry (MS/MS) was possible without further sample cleanup. We also show identification of other membrane proteins by this protocol, as proof of general applicability.
- 2 December 2004
- Published by Wiley in Proteomics
- Vol. 4 (12) , 3776-3782
Improved mass spectrometric identification of gel‐separated hydrophobic membrane proteins after sodium dodecyl sulfate removal by ion‐pair extraction
Separation and identification of hydrophobic membrane proteins is a major challenge in proteomics. Identification of such sodium dodecyl sulfate‐polyacrylamide gel electrophoresis (SDS‐PAGE)‐separated proteins by peptide mass fingerprinting (PMF) via matrix‐assisted laser desorption/ionization‐time of flight (MALDI‐TOF) is frequently hampered by the insufficient amount of peptides being generated and their low signal intensity. Using the seven helical transmembrane‐spanning proton pump bacteriorhodopsin as model protein, we demonstrate here that SDS removal from hydrophobic proteins by ion‐pair extraction prior to in‐gel tryptic proteolysis leads to a tenfold higher sensitivity in mass spectrometric identification via PMF, with respect to initial protein load on SDS‐PAGE. Furthermore, parallel sequencing of the generated peptides by electrospray ionization‐mass spectrometry (ESI‐MS) and tandem mass spectrometry (MS/MS) was possible without further sample cleanup. We also show identification of other membrane proteins by this protocol, as proof of general applicability.